Emcure Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 03, 2024, titled "Emcure Pharmaceuticals Signs Agreement with Gilead for the Manufacture and Global Supply of Lenacapavir".
Emcure Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 03, 2024, titled "Emcure Pharmaceuticals Signs Agreement with Gilead for the Manufacture and Global Supply of Lenacapavir".